Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Leukemia|November 16, 2019
The impact of anti-thymocyte globulin on the outcomes of Patients with AML with or without measurable residual disease at the time of allogeneic hematopoietic cell transplantationArnon Nagler, Bhagirathbhai Dholaria, Myriam Labopin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 9, 2018
18F-Fludarabine PET for Lymphoma Imaging: First-in-Humans Study on DLBCL and CLL PatientsSylvain Chantepie, Narinée Hovhannisyan, Stéphane Guillouet, et al.
British Journal of Haematology|March 15, 2023
A 16-month-long experience of COVID-19 in allogeneic haematopoietic stem cell transplantation recipients: An SFGM-TC multicentre cohort studyAliénor Xhaard, Constance Xhaard, Marie-Therese Rubio, et al.
Lupus Science & Medicine|July 29, 2025
Immune-mediated thrombotic thrombocytopenic purpura with systemic lupus erythematosus: clinical features and outcomeJúlia Weisinger, Raïda Bouzid, Jehane Fadlallah, et al.
Blood|April 23, 2020
Thromboembolism prophylaxis in adult patients with acute lymphoblastic leukemia treated in the GRAALL-2005 studyCorentin Orvain, Marie Balsat, Emmanuelle Tavernier, et al.
Bone Marrow Transplantation|March 22, 2024
Transplantation for myelofibrosis patients in the ruxolitinib era: a registry study from the Société Francophone de Greffe de Moelle et de Thérapie CellulaireSara Villar, Sylvie Chevret, Xavier Poire, et al.
Blood Cancer Journal|February 19, 2024
Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trialEolia Brissot, Myriam Labopin, Helene Labussière, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 17, 2018
Sequential Conditioning with Thiotepa in T Cell- Replete Hematopoietic Stem Cell Transplantation for the Treatment of Refractory Hematologic Malignancies: Comparison with Matched Related, Haplo-Mismatched, and Unrelated DonorsRémy Duléry, Anne-Lise Ménard, Sylvain Chantepie, et al.
Blood|December 28, 2019
Mutational profile and benefit of gemtuzumab ozogamicin in acute myeloid leukemiaElise Fournier, Nicolas Duployez, Benoît Ducourneau, et al.
Leukemia & Lymphoma|June 1, 2017
Increased frequencies of circulating and tumor-resident Vδ1+ T cells in patients with diffuse large B-cell lymphomaEmilie Reboursiere, Anne-Claire Gac, Anthony Garnier, et al.
Pageof 7